### Evidence Statement CG15AdultES111
On the balance of effectiveness and cost-effectiveness evidence, insulin glargine, which has a peakless action profile, is also recommended as a long-acting preparation for people with Ty pe 1 diabetes; 132 some studies in this review show significantly lower fasting blood glucose w ith insulin glargine than isophane (NPH) insulin and others suggest that people on insulin g largine may experience fewer hypoglycaemic ev ents than people receiving once-daily isophane (NPH) insulin 132

[@_NA__2008]

---
niceevidencecategory: NICE
...


